Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Paraquat Parkinson’s Disease Lawsuits Exposure to the toxic herbicide Paraquat has been linked to a risk of Parkinson's disease.
Gardasil HPV Vaccine Lawsuit Side effects of the Gardasil HPV vaccine have been linked to reports of serious and debilitating autoimmune injuries. Lawyers review cases nationwide.
Saphras Allergic Reaction Warning Issued by FDA September 2, 2011 Staff Writers Add Your Comments Reports of severe and potentially life-threatening allergic reactions have been linked to the side effects of Saphris, a relatively new atypical antipsychotic sold by Merck & Co. The FDA issued a drug safety communication on September 1, indicating that it has identified at least 52 cases of Saphris Type 1 hypersensitivity reactions through the FDA’s Adverse Event Reporting System (AERS). The agency reports that 19 cases resulted in hospitalization or emergency room visits, and seven patients required therapeutic interventions. The warning label for the drug is being updated to include information about the risk of Saphras allergic reactions, which the FDA said could be life-threatening. Do You Know About… Childhood Diabetes Lawsuits Against Junk Food Industry Lawyers are now pursuing financial compensation for families of children diagnosed with Type II diabetes, fatty liver disease and other chronic illnesses caused by addictive and harmful substances in ultra-processed foods. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… Childhood Diabetes Lawsuits Against Junk Food Industry Lawyers are now pursuing financial compensation for families of children diagnosed with Type II diabetes, fatty liver disease and other chronic illnesses caused by addictive and harmful substances in ultra-processed foods. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Symptoms of a reaction to Saphras could include anaphylaxis, swelling of the deeper layers of the skin (angioedema), low blood pressure, rapid heart rate, swollen tongue, difficulty breathing, wheezing and rash. In some cases multiple symptoms occurred following just one dose. Saphris (asenapine maleate) is an atypical antipsychotic approved by the FDA in August 2009 to treat symptoms of schizophrenia and bipolar disorder. Since approval, the drug has been prescribed about 235,000 times to about 87,000 patients in the United States. The FDA warned patients to seek emergency medical attention immediately if they develop signs of a Saphris allergic reaction. The agency also asked that serious Saphris side effects be reported to the AERS. Healthcare professionals were advised to educate patients in the signs and symptoms of Saphris hypersensitivity and to watch for anaphylaxis, angioedema, hypotension, tachycardia, swollen tongue, dyspnea, wheezing and rash in patients taking the antipsychotic. While some patients were able to resume Saphris treatments with no further reactions, the FDA contraindicated the drug for any patient that has shown signs of Saphris hypersensitivity. Saphris reactions and other side effects can be reported to the FDA’s AERS at MedWatch Online or by calling 1-800-332-1088. Tags: Allergic Reaction, Antipsychotics, Merck, Saphris More Lawsuit Stories Schedule for Hair Relaxer Lawsuit Bellwether Trials Outlined by MDL Judge March 13, 2025 Stone Fabricator Files Lawsuit Over Lung Disease, Silicosis From Quartz Countertops March 13, 2025 Study Finds Higher Suicide Rates Among Female Doctors Than Other Women March 13, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Schedule for Hair Relaxer Lawsuit Bellwether Trials Outlined by MDL Judge (Posted: yesterday) A federal judge has outlined the schedule for preparing a group of hair relaxer lawsuits for early bellwether trials, which will not go before a jury until at least 2027. MORE ABOUT: HAIR RELAXER LAWSUITSynthetic Braiding Hair Contains Cancer-Causing Chemicals: Consumer Reports (03/05/2025)Hair Relaxer Wrongful Death Lawsuit Links Fatal Endometrial Cancer to Chemical Straightener Use (03/04/2025)Hair Relaxer Lawsuit Settlement Talks Begin With Focus on Finding Mediator, Parties Report (02/11/2025) Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (Posted: 2 days ago) A BioZorb tissue marker lawsuit representing five women from across the country claims that the recalled implant was defectively designed, resulting in a recall and numerous complications. MORE ABOUT: BIOZORB LAWSUITBioZorb Attorneys Propose Leadership Structure for Lawsuits Over Recalled Tissue Marker (03/05/2025)Schedule Leading to First BioZorb Lawsuit Jury Trial in September 2025 Outlined By Court (02/21/2025)Judge Indicates BioZorb Recall and Warning Letter Do Not Warrant Reopening Discovery in Bellwether Cases (02/12/2025) Suboxone Lawyers Report on Status of Lawsuits Over Tooth Decay, Dental Damage (Posted: 3 days ago) Suboxone lawyers will meet today with a federal judge, to discuss the status of thousands of tooth decay lawsuits brought over the opioid treatment film strips. MORE ABOUT: SUBOXONE TOOTH DECAY LAWSUITMedical Records of Suboxone Tooth Decay Must Be Produced Under MDL Court Order (02/20/2025)Lawyers in Suboxone Dental Lawsuits Fail To Reach Agreement on Bellwether Selection Process (02/06/2025)Another Influx of Suboxone Tooth Decay Lawsuits Expected in Coming Months (01/20/2025)
Schedule for Hair Relaxer Lawsuit Bellwether Trials Outlined by MDL Judge (Posted: yesterday) A federal judge has outlined the schedule for preparing a group of hair relaxer lawsuits for early bellwether trials, which will not go before a jury until at least 2027. MORE ABOUT: HAIR RELAXER LAWSUITSynthetic Braiding Hair Contains Cancer-Causing Chemicals: Consumer Reports (03/05/2025)Hair Relaxer Wrongful Death Lawsuit Links Fatal Endometrial Cancer to Chemical Straightener Use (03/04/2025)Hair Relaxer Lawsuit Settlement Talks Begin With Focus on Finding Mediator, Parties Report (02/11/2025)
Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (Posted: 2 days ago) A BioZorb tissue marker lawsuit representing five women from across the country claims that the recalled implant was defectively designed, resulting in a recall and numerous complications. MORE ABOUT: BIOZORB LAWSUITBioZorb Attorneys Propose Leadership Structure for Lawsuits Over Recalled Tissue Marker (03/05/2025)Schedule Leading to First BioZorb Lawsuit Jury Trial in September 2025 Outlined By Court (02/21/2025)Judge Indicates BioZorb Recall and Warning Letter Do Not Warrant Reopening Discovery in Bellwether Cases (02/12/2025)
Suboxone Lawyers Report on Status of Lawsuits Over Tooth Decay, Dental Damage (Posted: 3 days ago) Suboxone lawyers will meet today with a federal judge, to discuss the status of thousands of tooth decay lawsuits brought over the opioid treatment film strips. MORE ABOUT: SUBOXONE TOOTH DECAY LAWSUITMedical Records of Suboxone Tooth Decay Must Be Produced Under MDL Court Order (02/20/2025)Lawyers in Suboxone Dental Lawsuits Fail To Reach Agreement on Bellwether Selection Process (02/06/2025)Another Influx of Suboxone Tooth Decay Lawsuits Expected in Coming Months (01/20/2025)